title: Challenges in the development of future treatments for breast cancer stem cells.
abstract: The recurrence of tumors after years of disease-free survival has spurred interest in the concept that cancers may have a stem cell basis. Current speculation holds that as few as 0.1% of the tumor mass may be chemoresistant and radioresistant, harboring stem-like properties that drive tumor survival, development, and metastasis. There are intense investigations to characterize cancer stem cells on the basis of self-renewal and multi-lineage differentiation. Thus far, no successful targeted therapies have been developed and reached the clinic, but as these cells are isolated and characterized, insights may be unraveled. In this review, we discuss the controversy over the origins of the cancer stem cell hypothesis and the unforeseen factors that may facilitate breast cancer stem cell survival and metastasis. We discuss the role of tumor microenvironment, including carcinoma-associated fibroblasts, epigenetic factors, and the Th1/Th2 balance, in supporting breast cancer stem cells. In addition, we have incorporated ideas on the epithelial-to-mesenchymal transition in metastatic dissemination of epithelial malignancies. This area is relevant since breast cancer stem cells have been suggested to revert to a mesenchymal phenotype during the progression of cancer. Finally we discuss prospects of developing targeted therapy including novel treatment modalities such as oncolytic viral therapy, differentiation therapy, and nanotechnology.
authors.affiliation: Graduate School of Biomedical Sciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA ; Department of Medicine - Division of Hematology/Oncology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
authors.forename: Shyam A
authors.initials: SA
authors.lastname: Patel
authors.affiliation: Department of Medicine - Division of Hematology/Oncology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
authors.forename: Anicia
authors.initials: A
authors.lastname: Ndabahaliye
authors.affiliation: Department of Medicine - Division of Hematology/Oncology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
authors.forename: Philip K
authors.initials: PK
authors.lastname: Lim
authors.affiliation: Department of Medicine - Division of Hematology/Oncology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
authors.forename: Russell
authors.initials: R
authors.lastname: Milton
authors.affiliation: Department of Medicine - Division of Hematology/Oncology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
authors.forename: Pranela
authors.initials: P
authors.lastname: Rameshwar
keywords: EMT; cancer stem cells; crosstalk; microenvironment; oncolytic viral therapy; side population
references.citation: Am J Pathol. 2003 Jul;163(1):3-9
references.pmid: 12819005
references.citation: Respirology. 2009 Aug;14(6):828-37
references.pmid: 19659836
references.citation: Int J Cancer. 2009 Jun 15;124(12):2771-9
references.pmid: 19296540
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12339-44
references.pmid: 12218177
references.citation: Curr Med Chem. 2008;15(30):3171-84
references.pmid: 19075661
references.citation: Stem Cells Dev. 2009 Dec;18(10):1515-22
references.pmid: 19260804
references.citation: Cell. 2008 May 16;133(4):704-15
references.pmid: 18485877
references.citation: Oncogene. 2007 Feb 26;26(9):1357-60
references.pmid: 17322922
references.citation: Neoplasia. 2007 Nov;9(11):882-92
references.pmid: 18030356
references.citation: Breast Cancer Res. 2009;11(3):R28
references.pmid: 19442295
references.citation: PLoS Biol. 2009 Jun 2;7(6):e1000121
references.pmid: 19492080
references.citation: Pathobiology. 2008;75(2):75-84
references.pmid: 18544962
references.citation: Cell. 2007 Dec 14;131(6):1109-23
references.pmid: 18083101
references.citation: Curr Cancer Drug Targets. 2007 Mar;7(2):133-9
references.pmid: 17346104
references.citation: J Cell Mol Med. 2008 Apr;12(2):374-90
references.pmid: 18182063
references.citation: Crit Rev Clin Lab Sci. 2009;46(4):190-209
references.pmid: 19650715
references.citation: Cell. 1994 May 20;77(4):491-502
references.pmid: 7910522
references.citation: Eur J Cancer. 2009 Sep;45 Suppl 1:11-26
references.pmid: 19775601
references.citation: Nat Med. 1999 Aug;5(8):881-7
references.pmid: 10426310
references.citation: Cancer Res. 2004 Dec 1;64(23):8604-12
references.pmid: 15574767
references.citation: Nat Med. 2001 Sep;7(9):1028-34
references.pmid: 11533706
references.citation: Curr Opin Mol Ther. 2009 Oct;11(5):532-9
references.pmid: 19806501
references.citation: Med Oncol. 2010 Sep;27(3):654-60
references.pmid: 19572217
references.citation: Cell. 2009 Aug 21;138(4):645-659
references.pmid: 19682730
references.citation: Ultrastruct Pathol. 2009 Jul-Aug;33(4):175-81
references.pmid: 19728235
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15665-70
references.pmid: 9861027
references.citation: Ann Clin Lab Sci. 2006 Winter;36(1):16-22
references.pmid: 16501232
references.citation: J Neurooncol. 2009 Oct;95(1):29-36
references.pmid: 19434372
references.citation: Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L97-104
references.pmid: 12626330
references.citation: Carcinogenesis. 2000 Jul;21(7):1271-9
references.pmid: 10874003
references.citation: Breast Cancer Res Treat. 2010 Jun;121(2):293-300
references.pmid: 19597705
references.citation: Nat Med. 1997 Dec;3(12):1337-45
references.pmid: 9396603
references.citation: J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):29-43
references.pmid: 19242781
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references.pmid: 12629218
references.citation: Cell Microbiol. 2009 Jun;11(6):889-97
references.pmid: 19388908
references.citation: PLoS Negl Trop Dis. 2009 Jul 14;3(7):e480
references.pmid: 19597544
references.citation: Endocr Metab Immune Disord Drug Targets. 2009 Dec;9(4):353-60
references.pmid: 19751196
references.citation: Nat Rev Cancer. 2003 Jun;3(6):453-8
references.pmid: 12778135
references.citation: Mol Ther. 2009 Oct;17(10):1677-82
references.pmid: 19672244
references.citation: Trends Genet. 2009 Jan;25(1):30-8
references.pmid: 19054589
references.citation: Stem Cells Dev. 2006 Jun;15(3):423-35
references.pmid: 16846378
references.citation: BMC Cancer. 2008 Dec 11;8:364
references.pmid: 19077243
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14867-72
references.pmid: 18806226
references.citation: Biochem Pharmacol. 2004 Nov 1;68(9):1729-38
references.pmid: 15450938
references.citation: Nat Med. 1997 Jul;3(7):730-7
references.pmid: 9212098
references.citation: Exp Cell Res. 2004 Apr 15;295(1):79-90
references.pmid: 15051492
references.citation: Mol Cancer Ther. 2009 Aug;8(8):2096-102
references.pmid: 19671759
references.citation: Nanotechnology. 2009 Feb 4;20(5):055103
references.pmid: 19417334
references.citation: J Clin Invest. 2007 Nov;117(11):3155-63
references.pmid: 17975657
references.citation: Cancer Res. 2008 Jun 1;68(11):4331-9
references.pmid: 18519693
references.citation: Cancer Res. 2005 Jul 15;65(14):6207-19
references.pmid: 16024622
references.citation: Breast Cancer Res. 2003;5(1):R1-8
references.pmid: 12559051
references.citation: PLoS One. 2008 Jun 25;3(6):e2563
references.pmid: 18575622
references.citation: Cancer Cell. 2007 Mar;11(3):259-73
references.pmid: 17349583
references.citation: Clin Cancer Res. 2002 Jan;8(1):22-8
references.pmid: 11801536
references.citation: Breast Cancer. 2009;16(4):268-74
references.pmid: 19459031
references.citation: Mol Cell Biochem. 2007 Dec;306(1-2):201-12
references.pmid: 17660947
references.citation: J Cell Sci. 2000 Feb;113 ( Pt 3):409-23
references.pmid: 10639329
references.citation: Methods Mol Biol. 2009;542:607-34
references.pmid: 19565924
references.citation: Nat Med. 2009 Aug;15(8):907-13
references.pmid: 19648928
references.citation: Oncogene. 2003 Oct 20;22(47):7340-58
references.pmid: 14576842
references.citation: Cell Stem Cell. 2007 Nov;1(5):555-67
references.pmid: 18371393
references.citation: Anticancer Res. 2009 Jun;29(6):2147-57
references.pmid: 19528475
references.citation: Cell. 2009 Aug 7;138(3):592-603
references.pmid: 19665978
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5
references.pmid: 19666588
references.citation: Cancer Res. 2009 Aug 15;69(16):6704-12
references.pmid: 19654291
references.citation: J Cell Sci. 2000 Jun;113 ( Pt 11):2011-21
references.pmid: 10806112
references.citation: Biochem Pharmacol. 2009 Aug 15;78(4):326-34
references.pmid: 19539800
references.citation: J Cell Biol. 2004 Oct 25;167(2):215-21
references.pmid: 15492044
references.citation: Am J Physiol Lung Cell Mol Physiol. 2004 Apr;286(4):L624-30
references.pmid: 12909587
references.citation: Biochem Biophys Res Commun. 2002 May 3;293(2):670-4
references.pmid: 12054520
references.citation: Cancer Res. 2008 Jul 15;68(14):5533-9
references.pmid: 18632604
references.citation: Ann N Y Acad Sci. 2009 Feb;1155:284-8
references.pmid: 19250218
references.citation: PLoS One. 2009 Jul 28;4(7):e6381
references.pmid: 19636430
references.citation: Exp Cell Res. 2004 Jul 15;297(2):444-60
references.pmid: 15212947
references.citation: Bioessays. 2009 Oct;31(10):1038-49
references.pmid: 19708024
references.citation: Med Hypotheses. 2009 Oct;73(4):542-7
references.pmid: 19564079
references.citation: Hepatobiliary Pancreat Dis Int. 2009 Apr;8(2):174-8
references.pmid: 19357032
references.citation: Breast Dis. 2004;20:3-11
references.pmid: 15687702
references.citation: J Cell Biol. 2002 Oct 14;159(1):123-34
references.pmid: 12379804
references.citation: Histol Histopathol. 2009 Mar;24(3):385-98
references.pmid: 19130408
references.citation: J Clin Oncol. 2008 Jun 10;26(17):2813-20
references.pmid: 18539959
references.citation: Nanotechnology. 2009 Feb 11;20(6):065101
references.pmid: 19417369
references.citation: Cell. 2008 Feb 8;132(3):397-409
references.pmid: 18267072
references.citation: Mol Pharm. 2009 Jul-Aug;6(4):1100-9
references.pmid: 19419197
references.citation: Mol Ther. 2009 Jun;17(6):972-9
references.pmid: 19293772
references.citation: PLoS One. 2008 Aug 06;3(8):e2888
references.pmid: 18682804
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14228-33
references.pmid: 15381773
references.citation: Cancer Res. 2006 Jun 15;66(12):6063-71
references.pmid: 16778178
references.citation: J Clin Invest. 2009 Aug;119(8):2119-23
references.pmid: 19620782
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1680-5
references.pmid: 18230721
references.citation: Breast Cancer Res. 2004;6(6):R605-15
references.pmid: 15535842
references.citation: Nat Biotechnol. 2003 Jan;21(1):41-6
references.pmid: 12459735
references.citation: Breast Cancer Res Treat. 2009 Jun;115(3):453-95
references.pmid: 18841463
references.citation: J Am Soc Nephrol. 2006 Jul;17(7):1896-912
references.pmid: 16707564
references.citation: Cancer Res. 2009 May 15;69(10):4116-24
references.pmid: 19435916
references.citation: Eur J Gynaecol Oncol. 2000;21(4):411-5
references.pmid: 11055498
references.citation: Hum Pathol. 2009 Sep;40(9):1224-33
references.pmid: 19439346
references.citation: Oncol Rep. 2009 Nov;22(5):1181-7
references.pmid: 19787238
references.citation: Cancer Res. 2008 Sep 1;68(17):6932-41
references.pmid: 18757407
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15649-54
references.pmid: 12429862
references.citation: Ann Hematol. 2002 Jul;81(7):397-8
references.pmid: 12185512
references.citation: Genes Dev. 2003 May 15;17(10):1253-70
references.pmid: 12756227
references.citation: Cancer Res. 2009 Apr 1;69(7):2887-95
references.pmid: 19276366
references.citation: Blood. 2003 Oct 1;102(7):2436-43
references.pmid: 12805065
references.citation: J Invest Dermatol. 2008 Feb;128(2):280-91
references.pmid: 17671518
references.citation: BMC Cancer. 2009 Aug 20;9:289
references.pmid: 19695091
references.citation: Hum Gene Ther. 2006 Nov;17(11):1152-60
references.pmid: 17032151
references.citation: Cancer Res. 2008 Dec 15;68(24):10257-66
references.pmid: 19074894
references.citation: Blood. 2002 Jan 15;99(2):507-12
references.pmid: 11781231
references.citation: Exp Cell Res. 2004 Aug 1;298(1):144-54
references.pmid: 15242769
references.citation: Oncogene. 2008 Sep 1;27(38):5124-31
references.pmid: 18758481